Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Shares Issued (2019 - 2025)

Korro Bio (KRRO) has disclosed Shares Issued for 6 consecutive years, with $305000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Issued fell 99.55% year-over-year to $305000.0, compared with a TTM value of -$65.1 million through Sep 2025, down 196.12%, and an annual FY2024 reading of $2.0 million, up 180.63% over the prior year.
  • Shares Issued was $305000.0 for Q3 2025 at Korro Bio, up from -$172000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $67.1 million in Q3 2024 and bottomed at -$65.4 million in Q4 2024.
  • Average Shares Issued over 5 years is $182294.1, with a median of $82000.0 recorded in 2023.
  • Peak annual rise in Shares Issued hit 30952.31% in 2024, while the deepest fall reached 18630.88% in 2024.
  • Year by year, Shares Issued stood at -$1000.0 in 2021, then soared by 300.0% to $2000.0 in 2022, then soared by 17550.0% to $353000.0 in 2023, then tumbled by 18630.88% to -$65.4 million in 2024, then soared by 100.47% to $305000.0 in 2025.
  • Business Quant data shows Shares Issued for KRRO at $305000.0 in Q3 2025, -$172000.0 in Q2 2025, and $172000.0 in Q1 2025.